Results 21 to 30 of about 251,619 (354)

Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database

Brain Sciences, 2020
Background: Clozapine is of high clinical relevance for the management of both treatment-resistant schizophrenia and psychotic disturbances with concurrent drug misuse.
Stefania Chiappini, Fabrizio Schifano, John Martin Corkery, Amira Guirguis   +3 more
doaj   +1 more source

Synthetic cannabinoid use in a case series of patients with psychosis presenting to acute psychiatric settings : Clinical presentation and management issues [PDF]

, 2018
Background: Novel Psychoactive Substances (NPS) are a heterogeneous class of synthetic molecules including synthetic cannabinoid receptor agonists (SCRAs). Psychosis is associated with SCRAs use.
Bonaccorso, Stefania, Ducci, Giuseppe, Ferracuti, Stefano, Jamal, Leila, Metastasio, Antonio, Ricciardi, Angelo, Rujully, Naasir Ud Dinn, Schifano, Fabrizio, Stewart, Neil, Theleritis, Christos   +9 more
core   +3 more sources

The Psychonauts’ World of Cognitive Enhancers

Frontiers in Psychiatry, 2020
BackgroundThere is growing availability of novel psychoactive substances (NPS), including cognitive enhancers (CEs) which can be used in the treatment of certain mental health disorders.
Flavia Napoletano, Flavia Napoletano, Fabrizio Schifano, John Martin Corkery, Amira Guirguis, Amira Guirguis, Davide Arillotta, Davide Arillotta, Caroline Zangani, Caroline Zangani, Alessandro Vento, Alessandro Vento, Alessandro Vento   +12 more
doaj   +1 more source

Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration’s FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset

Pharmaceuticals, 2023
Recent media reports commented about a possible issue of the misuse of antidiabetics related to molecules promoted as a weight-loss treatment in non-obese people.
Stefania Chiappini, Rachel Vickers-Smith, Daniel Harris, G. Duccio Papanti Pelletier, John Martin Corkery, Amira Guirguis, Giovanni Martinotti, Stefano L. Sensi, Fabrizio Schifano   +8 more
doaj   +1 more source

Class A drug abuse: an ophthalmologist's problem? [PDF]

, 2005
[First Paragraph] The 2002/3 British Crime Survey reported that 3% of all 16 to 59 year olds (equating to around one million people) had used a class A drug in the last year.
Firth, A.Y.
core   +1 more source

Understanding the Opioid Epidemic through Pharmacovigilance Signals: an Analysis of Pharmacovigilance Datasets collecting Adverse Drug Reactions (ADRs) reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS) over 10 Years

Emerging Trends in Drugs, Addictions, and Health
Introduction: In the past twenty years, the consumption of opioid medications has reached significant proportions, leading to the so-called opioid epidemic, characterized by cyclical waves of heroin use and the non-medical use of pharmaceutical opioids ...
S. Chiappini, R. Vickers-Smith, A. Guirguis, J. Corkery, G. Martinotti, D.R. Harris, F. Schifano   +6 more
doaj   +1 more source

The Bridge Between Classical and “Synthetic”/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective

Frontiers in Psychiatry, 2019
The critical spread and dissemination of novel psychoactive substances (NPS), particularly among the most vulnerable youngsters, may pose a further concern about the psychotic trajectories related to the intake of new synthetic drugs.
Laura Orsolini, Laura Orsolini, Laura Orsolini, Stefania Chiappini, Duccio Papanti, Domenico De Berardis, Domenico De Berardis, Domenico De Berardis, John M. Corkery, Fabrizio Schifano   +9 more
doaj   +1 more source

Case Report: Treatment of Kratom Use Disorder With a Classical Tricyclic Antidepressant

Frontiers in Psychiatry, 2021
Kratom or Mitragyna speciosa (Korth.) is an evergreen tree of the coffee family native to South-East Asia and Australasia. It is used by locals recreationally to induce stimulant and sedative effects and medically to soothe pain and opiate withdrawal ...
Alessandro E. Vento, Alessandro E. Vento, Simone de Persis, Sergio De Filippis, Fabrizio Schifano, Flavia Napoletano, John M. Corkery, Georgios D. Kotzalidis, Georgios D. Kotzalidis   +8 more
doaj   +1 more source

Predicting the early therapeutic alliance in the treatment of drug misuse [PDF]

, 2005
Aims - To predict the early therapeutic alliance from a range of potentially relevant factors, including clients' social relationships, motivation and psychological resources, and counsellors' professional experience and ex-user status.
Barber, Barber, Bartholomew, Belding, Broome, Connors, De Weert-Van Oene, De Weert-Van Oene, Department of Health, Department of Health, Dunkle, Eames, Fenton, Fiorentine, Gaston, Gerstley, Gomes-Schwartz, Gossop, Gossop, Griffin, Hersoug, Horvath, Horvath, Joe, Joe, Joe, Kivlighan, Knight, Kokotovic, Liese, Litman, LoSciuto, Luborsky, Luborsky, Mallinckrodt, Mallinckrodt, Mallinckrodt, Mallinckrodt, Marsden, Martin, Marziali, McLellan, Meier, Moras, Petry, Scharfe, Simpson, Simpson, Stanton, Tracey, Tryon   +50 more
core   +1 more source

Benzodiazepine Boom: Tracking Etizolam, Pyrazolam, and Flubromazepam from Pre-UK Psychoactive Act 2016 to Present Using Analytical and Social Listening Techniques

Pharmacy
Introduction: The designer benzodiazepine (DBZD) market continues to expand whilst evading regulatory controls. The widespread adoption of social media by pro-drug use communities encourages positive discussions around DBZD use/misuse, driving demand ...
Anthony Mullin, Mark Scott, Giorgia Vaccaro, Giuseppe Floresta, Davide Arillotta, Valeria Catalani, John M. Corkery, Jacqueline L. Stair, Fabrizio Schifano, Amira Guirguis   +9 more
doaj   +1 more source